Activity of gemcitabine in platinum-resistant ovarian germ cell cancer
- 1 July 1996
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (8) , 1437-1438
- https://doi.org/10.1016/0959-8049(96)00128-1
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerAnnals of Oncology, 1996
- Management of Early Ovarian Cancer: Germ Cell and Sex Cord-Stromal TumorsGynecologic Oncology, 1994
- Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.Journal of Clinical Oncology, 1994
- Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Update on malignant ovarian germ cell tumorsCancer, 1993